Carbon Nanoarchitectures: Toxicity Barrier and Therapeutic Advancement
Chemical Research in Toxicology · 2025
DOI: 10.1021/acs.chemrestox.4c00529 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Research in Toxicology, 2025. Verfasst von Santosh Ganguly und 4 weiteren Autor:innen. Beteiligte Einrichtung: Bharat Pharmaceutical Technology, Amtali, NH-08, Tripura (W)799130, India. Hauptthemen laut MEDLINE: Carbon, Nanostructures. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 246 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bharat Pharmaceutical Technology, Amtali, NH-08, Tripura (W)799130, India.
- Department of Pharmaceutical Technology, JIS University, 81, Nilgunj Road, Agarpara, West Bengal 700109, India.
- Department of Human Physiology, Tripura University, Suryamaninagar, Tripura (W)799022, India.
- Department of Pharmaceutical Chemistry, Bharat Technology, Banitabla, Uluberia, Howrah, West Bengal 711316, India.
ORCID-Profile: Santosh Ganguly, Samir Kumar Sil
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Ganguly, S., Sarkar, P., Sarkar, D., Debnath, B., & Sil, S. K. (2025). Carbon Nanoarchitectures: Toxicity Barrier and Therapeutic Advancement. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.4c00529
Vancouver
Ganguly S, Sarkar P, Sarkar D, Debnath B, Sil SK. Carbon Nanoarchitectures: Toxicity Barrier and Therapeutic Advancement. Chemical Research in Toxicology. 2025. doi:10.1021/acs.chemrestox.4c00529
BibTeX
@article{Ganguly2025,
author = {Ganguly, Santosh and Sarkar, Priyatosh and Sarkar, Debjani and Debnath, Biplab and Sil, Samir Kumar},
title = {Carbon Nanoarchitectures: Toxicity Barrier and Therapeutic Advancement},
journal = {Chemical Research in Toxicology},
year = {2025},
doi = {10.1021/acs.chemrestox.4c00529}
}
EUVIMED